Phibro Animal Health (NASDAQ:PAHC) reported fiscal third-quarter 2026 results that management characterized as a “strong third quarter,” with growth in sales and adjusted earnings and updated full-year...
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference. Executive Vice President, Corporate Strategy & CEO...
Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2026, and its updated financial guidance for...
Barchart Research What to Expect from PAHC Earnings PAHC Generated May 5, 2026 Current Price $56.24 EPS Estimate $$0.72 Consensus Rating Moderate Buy Average Move 9.82% Can Phibro Animal Health Justify...
The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the launch of its new Sustainable Solutions Platform (SSP) , a companywide initiative designed to help animal protein, dairy...
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 6, 2026, after the market closes. Phibro management will host a conference call...
Phibro Animal Health Corporation (Nasdaq: PAHC) today announced expected implementation of a new regulatory framework governing the use of certain antimicrobials in Brazil that have growth promotion indications....